H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy

H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.